External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Thorax

• Publication date

  2006-11-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.2006.066837PMID 17105779PMCID PMC2117157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Physiological associations of computerized tomography lung density: a factor analysis

  2006influential reference
• Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease

  2006cited by this paper
• External validity of randomised controlled trials: "to whom do the results of this trial apply?".

  2005cited by this paper
• Spirometric criteria for asthma: adding further evidence to the debate.

  2005cited by this paper
• How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease?

  2005cited by this paper
• Clinical phenotypes of asthma.

  2004cited by this paper
• Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma.

  2003influential reference
• Clinical trials: are these your patients?

  2003cited by this paper
• The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma.

  2003cited by this paper
• Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma

  2003cited by this paper
• Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.

  2003cited by this paper
• Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma.

  2003cited by this paper
• Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma

  2003cited by this paper
• Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

  2002influential reference
• Global initiative for chronic obstructive lung disease.

  2002cited by this paper
• Representation of the elderly, women, and minorities in heart failure clinical trials.

  2002cited by this paper
• Gender Bias in Clinical Trials: Do Double Standards Still Apply?

  2001cited by this paper
• Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.

  2001cited by this paper
• Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial.

  2001cited by this paper
• Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.

  2001cited by this paper
• Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial.

  2001cited by this paper
• Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma.

  2000cited by this paper
• Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.

  2000cited by this paper
• The prevalence of asthma symptoms, bronchial hyperresponsiveness and atopy in New Zealand adults.

  1999cited by this paper
• Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.

  1999cited by this paper
• Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

  1999cited by this paper
• Underrepresentation of patients 65 years of age or older in cancer-treatment trials.

  1999cited by this paper
• Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement

  1999cited by this paper
• Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma.

  1998cited by this paper
• Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group.

  1998cited by this paper
• Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.

  1998cited by this paper
• Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

  1997cited by this paper
• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

  1996cited by this paper
• Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.

  1996cited by this paper
• Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison.

  1996cited by this paper
• Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group.

  1994cited by this paper
• The self reported prevalence of asthma symptoms amongst adult New Zealanders.

  1994cited by this paper
• Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease.

  1993cited by this paper
• Prevalence of asthma symptoms among adolescents in the Wellington region, by area and ethnicity.

  1993cited by this paper

• Step-by-step causal analysis of EHRs to ground decision-making

  2025cites this paper
• Normal FEV1 without Reversibility in Asthma Trials - A Placebo Patient-Level Meta-Analysis.

  2025cites this paper
• The Rapidly Evolving Landscape of Asthma Therapies Is Exhilarating, Yet a Lack of Innovation in Clinical Trial Design Makes Feasibility a Real Concern

  2025cites this paper
• Designing studies and reviews to produce informative, trustworthy evidence about complex interventions in rehabilitation: a narrative review and commentary

  2024cites this paper
• Action-plan and as-needed therapy in allergic rhinitis

  2024cites this paper
• Asthma prescribing trends, inhaler adherence and outcomes: a Real-World Data analysis of a multi-ethnic Asian Asthma population

  2024cites this paper
• Do patients with type 2 diabetes mellitus included in randomised clinical trials differ from general-practice patients? A cross-sectional comparative study

  2024cites this paper
• On the Generalizability of Machine Learning Classification Algorithms and Their Application to the Framingham Heart Study

  2024cites this paper
• Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis

  2024cites this paper
• Bronchodilator Responsiveness in Asthma and Chronic Obstructive Pulmonary Disease: Time to Stop Chasing Shadows

  2024cites this paper
• Cardiovascular Events in Patients with Severe Asthma—A Retrospective Study of Two Cohorts: Asthma Type T2 Treated with Biologics and Non-Type T2

  2024cites this paper
• Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial

  2024cites this paper
• Racial and Ethnic Disparities in Antihypertensive Medication Prescribing Patterns and Effectiveness

  2024cites this paper
• Cluster analyses from the real-world NOVELTY study: six clusters across the asthma-COPD spectrum.

  2023cites this paper
• Efficacy of Slow-Release L-cysteine (AcetiumTM Capsules)* in Prevention of Exacerbation of Bronchial Asthma

  2023influential citation
• Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement

  2023cites this paper
• Pain Medications Used by Persons Living With Fibromyalgia: A Comparison Between the Profile of a Quebec Sample and Clinical Practice Guidelines

  2023cites this paper
• Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness

  2023cites this paper
• Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers.

  2023cites this paper
• Fixed-dose combination fluticasone/formoterol for asthma treatment in a real-world setting: meta-analysis of exacerbation rates and asthma control

  2023cites this paper
• Improving Rehabilitation Research to Optimize Care and Outcomes for People with Chronic Primary Low Back Pain: Methodological and Reporting Recommendations from a WHO Systematic Review Series

  2023cites this paper
• Impact of Anti-IL5 Therapies on Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study

  2023influential citation
• Exploring Differences in Screening and Enrollment Metrics in Orthopaedic Clinical Trials

  2023cites this paper
• Assessment of Change in Practice of Routine Tracheal Suctioning Approach of Non-Vigorous Infants Born through Meconium-Stained Amniotic Fluid: A Pragmatic Systematic Review and Meta-Analysis of Evidence outside Randomized Trials

  2023cites this paper
• Real-life studies and registries of severe asthma: The advent of digital technology.

  2023cites this paper
• Individualised risk prediction model for exacerbations in patients with severe asthma: protocol for a multicentre real-world risk modelling study

  2023cites this paper
• The treatable traits approach to adults with obstructive airways disease in primary and secondary care

  2023cites this paper
• Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air® approach

  2023cites this paper
• Deficiencies in reporting inclusion/exclusion criteria and characteristics of patients in randomized controlled trials of therapeutic interventions in pressure injuries: a systematic methodological review

  2023cites this paper
• THE ICS/FORMOTEROL RELIEVER THERAPY REGIMEN IN ASTHMA: A REVIEW.

  2023cites this paper
• Does weight management research for adults with severe obesity represent them? Analysis of systematic review data

  2022cites this paper
• Gender Differences in Medication Adverse Effects Experienced by People Living With Chronic Pain

  2022cites this paper
• The need for guidelines in everyday clinical practice: Today: Good, bad, ugly

  2022cites this paper
• The Role of Smoking in Asthma and Chronic Obstructive Pulmonary Disease Overlap.

  2022cites this paper
• Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial

  2022cites this paper
• Real-Life Performance of Mepolizumab in T2-High Severe Refractory Asthma with the Overlapping Eosinophilic-Allergic Phenotype

  2022cites this paper
• Real‐world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta‐analysis

  2022cites this paper
• Methodology to standardize heterogeneous statistical data presentations for combining time-to-event oncologic outcomes

  2022cites this paper
• Treatable traits in the NOVELTY study

  2022cites this paper
• Comparing two identically protocolized, multicentre, randomized controlled trials on caregiver-mediated exercises poststroke: Any differences across countries?

  2022cites this paper
• Clinical evaluation versus magnetic resonance imaging findings in patients with radicular arm pain—A pragmatic study

  2022cites this paper
• Roles of real-world evidence in severe asthma treatment: challenges and opportunities

  2022cites this paper
• Timing of dialysis in acute kidney injury using routinely collected data and dynamic treatment regimes

  2022cites this paper
• Evolving Concept of Severe Asthma: Transition From Diagnosis to Treatable Traits

  2022cites this paper
• Drug-resistant tuberculosis: Promising progress with a note of caution

  2022cites this paper
• Treatable traits in asthma: moving beyond diagnostic labels

  2022cites this paper
• Outcome-Based Reimbursement: The Solution to High Drug Spending?

  2022cites this paper
• Does the asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS) exist? A narrative review from epidemiology and practice.

  2022cites this paper
• Triple Therapy of Asthma-Permutations and Combinations.

  2022cites this paper
• External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia

  2022cites this paper
• Recent Insights into the Management of Inflammation in Asthma

  2021cites this paper
• Sociodemographic and clinical characteristics in child and youth mental health; comparison of routine outcome measurements of an Australian and Dutch outpatient cohort

  2021cites this paper
• Asthma biologic trial eligibility and real-world outcomes in the United States

  2021cites this paper
• SMART for the treatment of asthma: A network meta-analysis of real-world evidence.

  2021cites this paper
• COVID-19, loneliness, social isolation and risk of dementia in older people: a systematic review and meta-analysis of the relevant literature

  2021cites this paper
• Objectivity for the research worker

  2021cites this paper
• Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence

  2021cites this paper
• The challenges of assessing sample representativeness within community-based evaluations of parenting programmes delivered in England and Ireland.

  2021cites this paper
• Outcomes of Antibiotics in Adults with “Difficult to Treat” Asthma or the Overlap Syndrome

  2021cites this paper
• Does COPD start in the nursery?

  2021cites this paper
• Combined therapy with inhaled glucocorticosteroids and long-acting β2-agonists in patients with bronchial asthma: the problem of choice

  2021cites this paper
• Real‐world Omalizumab and Mepolizumab treated difficult asthma phenotypes and their clinical outcomes

  2021cites this paper
• Chlamydia pneumoniae and chronic asthma: Updated systematic review and meta-analysis of population attributable risk

  2021cites this paper
• Asthma Patients Who Stop Asthma Biologics Have a Similar Risk Of Asthma Exacerbations as Those Who Continue Asthma Biologics.

  2021cites this paper
• Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity

  2021cites this paper
• Quantifying causality in data science with quasi-experiments

  2021cites this paper
• Rates of Major Cardiovascular Events in Severe Asthma: U.S. Real-World and Clinical Trial–Eligible Populations

  2021cites this paper
• Reply: About the recommendation of the GINA strategy report on asthma step 1

  2021cites this paper
• Principles of Experimental Design

  2021cites this paper
• Comparison of the outcomes of the prolonged antianginal therapy use in stable coronary artery disease patients according to the data of randomized and observational studies

  2021cites this paper
• Using external data to assess the external validity of a randomised controlled trial

  2021cites this paper
• Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement

  2021cites this paper
• Feasibility of effectiveness trials in pediatric anesthesia

  2021cites this paper
• Examination of exclusion criteria in total knee arthroplasty rehabilitation trials: influence on the application of evidence in day-to-day practice.

  2021cites this paper
• Perspectives on decisions for treatment and care in severe asthma

  2021cites this paper
• Continuous positive airway pressure and adverse cardiovascular events in obstructive sleep apnea: Are participants of randomized trials representative of sleep clinic patients?

  2021cites this paper
• Chasing Your Long Tails: Differentially Private Prediction in Health Care Settings

  2020cites this paper
• Relative efficiencies of alternative preference-based designs for randomised trials

  2020cites this paper
• Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design

  2020cites this paper
• Perinatal death in a term fetal growth restriction randomized controlled trial: the paradox of prior risk and consent.

  2020cites this paper
• A randomized, open-label, pragmatic study to assess reliever-triggered inhaled corticosteroid in African American/Black and Hispanic/Latinx adults with asthma: Design and methods of the PREPARE trial

  2020cites this paper
• Ethical Machine Learning in Health Care

  2020cites this paper
• Aspirin and low-dose rivaroxaban – the dual pathway concept in patients with stable atherosclerotic disease: a comprehensive review

  2020cites this paper
• The Promise, and Challenges, of Methods to Enhance the External Validity of Randomized Trial Results

  2020cites this paper
• External validity of type 2 diabetes clinical trials on cardiovascular outcomes for a multimorbid population

  2020cites this paper
• The myth of generalisability in clinical research and machine learning in health care

  2020cites this paper
• Beyond Randomized Clinical Trials: Emerging Innovations in Reasoning About Health

  2020cites this paper
• Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study

  2020cites this paper
• Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap

  2020cites this paper
• Causal Evidence and Dispositions in Medicine and Public Health

  2020cites this paper
• Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study

  2020cites this paper
• Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma–COPD overlap

  2020cites this paper
• Adherence to Adding Inhaled Corticosteroids to Rescue Therapy in a Pragmatic Trial with Adults with Asthma- a Pilot Study.

  2020cites this paper
• Utility of Perioperative Warming for the Prevention of Surgical Site Infection and Patient Rehabilitative Complications: A Systematic Review

  2020cites this paper
• COPD_A_241568 701..710

  2020cites this paper
• Effectiveness of beclometasone dipropionate and formoterol in an extrafine particle formulation for asthma therapy depending on patient smoking status: the CASPER noninterventional, observational trial

  2020cites this paper
• Treatment effects may remain the same even when trial participants differed from the target population.

  2020cites this paper
• Real-World Data and Randomised Controlled Trials: The Salford Lung Study

  2020cites this paper
• Defining severe obstructive lung disease in the biologic era: an endotype-based approach

  2019cites this paper
• The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group

  2019cites this paper